HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance.

AbstractBACKGROUND:
Most studies dichotomise indices of coronary microvascular function to assess their prognostic values.
AIMS:
We aimed to investigate whether coronary flow reserve (CFR) and hyperaemic microvascular resistance (HMR) as continua predict major adverse cardiovascular events (MACE), comprising all-cause death, myocardial infarction, revascularisation, and stroke in patients with ischaemia and non-obstructive coronary artery disease.
METHODS:
A total of 610 patients were included and followed up over a median of 8.0 years (199 individual MACE in 174 patients).
RESULTS:
Both CFR and HMR as continua predicted MACE with an odds ratio (OR) of 0.70 (per 1-unit increase, 95% confidence interval [CI]: 0.53, 0.92; p=0.01) and 1.63 (per 1 mmHg/cm/s, 95% CI: 1.20, 2.21; p=0.002), respectively. This relationship remained significant after adjustment for age and sex with an adjusted OR of 0.66 (per 1 unit increase, 95% CI: 0.49, 0.89; p=0.01) and 1.42 (per 1 mmHg/cm/s, 95% CI: 1.03, 1.94; p=0.03). HMR added prognostic value to CFR in predicting MACE (net reclassification index 0.17, 95% CI: 0.02, 0.31; p=0.03; integrated discrimination improvement 0.01, 95% CI: 0.0001, 0.02; p=0.046).
CONCLUSIONS:
Both CFR and HMR as continuous variables predict future risk of MACE.
AuthorsTakumi Toya, Michel T Corban, Ji Young Park, Ali Ahmad, Ilke Ӧzcan, Faten Sebaali, Jaskanwal D S Sara, Rajiv Gulati, Lilach O Lerman, Amir Lerman
JournalEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (EuroIntervention) Vol. 17 Issue 7 Pg. 569-575 (Sep 20 2021) ISSN: 1969-6213 [Electronic] France
PMID33342762 (Publication Type: Journal Article)
Topics
  • Coronary Artery Disease (diagnostic imaging)
  • Fractional Flow Reserve, Myocardial
  • Humans
  • Hyperemia
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: